Study of 10-year-old flu samples finds virus’s evolution in individual transplant patients partially mirrors later global trends
June 27, 2017
| By Rachel Tompa / Fred Hutch News Service
When it comes to the flu, a few infected people may speak for the multitude. Evolutionary biologists have found that evolution in individual infections has parallels to the virus's later global evolution.
Dr. Colleen Delaney leads first test of "off-the-shelf" cord blood cell product outside the transplant setting; Dr. Justin Taylor receives Hartwell Foundation award to research alternative to RSV vaccine
Antiviral drug for post-transplant complications now costs more than the transplant
June 2, 2016
| By Mary Engel / Fred Hutch News Service
A life-saving antiviral drug used to treat a type of severe pneumonia in children and adults who have undergone bone marrow transplants can now cost more than the transplant itself after the drug’s sole distributor, Valeant Pharmaceuticals, increased the price by almost 400 percent.
Fred Hutch is proud to be an Equal Opportunity and VEVRAA Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability, marital or veteran status, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. Read the EEO is the Law poster here.